Tango Therapeutics (TNGX) Moves 10.3% Higher: Will This Strength Last? [Yahoo! Finance]
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Tango Therapeutics, Inc. (NASDAQ: TNGX) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at HC Wainwright from $16.00 to $13.00. They now have a "buy" rating on the stock.
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at Guggenheim from $16.00 to $14.00. They now have a "buy" rating on the stock.